Indapamid-TEVA SR coated tablets with prolonged release 1.5 mg. №30

$22.00

Manufacturer: Germany

Purpose: Indapamide-TEVA SR targets hypertension by promoting diuresis, reducing blood pressure.

SKU: MED58853 Category:

Description

Indapamid-TEVA SR Coated Tablets with Prolonged Release 1.5 mg. №30

Ingredients

Each tablet contains 1.5 mg of Indapamide.

Dosage

The recommended dosage is one tablet daily, preferably in the morning.

Indications

Indapamid-TEVA SR is indicated for the treatment of hypertension. It helps to lower blood pressure and reduce the risk of stroke and heart attacks.

Contraindications

Do not use Indapamid-TEVA SR if you are allergic to indapamide or if you have severe kidney problems. It is not recommended for use during pregnancy.

Directions

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. It is important to take the medication regularly to experience its full benefits.

Scientific Evidence

Indapamide, the active ingredient in Indapamid-TEVA SR, is a thiazide-like diuretic that works by increasing the excretion of sodium and water, leading to decreased blood volume and lowered blood pressure. Studies have shown that indapamide is effective in reducing blood pressure and preventing cardiovascular events. Research published in the Journal of Hypertension demonstrated the long-term efficacy and safety of indapamide in the management of hypertension.

Additional Information

Indapamid-TEVA SR coated tablets with prolonged release 1.5 mg offer a convenient once-daily dosing regimen, improving patient adherence to treatment. It is important to monitor electrolyte levels periodically while taking this medication to prevent imbalances. Consult your healthcare provider for personalized advice on the use of Indapamid-TEVA SR.

Indapamid-TEVA SR provides a sustained release of the active ingredient, ensuring a steady blood level over 24 hours. This prolonged release formulation reduces the frequency of dosing and minimizes potential side effects associated with rapid fluctuations in drug concentration. Clinical trials have shown that the extended-release formulation of indapamide offers comparable efficacy to immediate-release formulations with improved tolerability and compliance.

Compared to other antihypertensive medications, Indapamid-TEVA SR has shown similar efficacy in lowering blood pressure with a lower risk of adverse effects such as hypokalemia. Its unique pharmacological profile makes it a valuable option for the management of hypertension, especially in patients requiring long-term treatment.